Dr. Miele Cosmed Group S.a.GPW: DMG

Dr. Miele Cosmed Group: Stable Position Despite Geopolitical Challenges and Cost Pressures

· Issued by Dr. Miele Cosmed Group S.a.
Dr. Miele Cosmed Group: Stable Position Despite Geopolitical Challenges and Cost Pressures

17.09.2026

In the first half of 2026, the Group's consolidated revenue amounted to PLN 241.2 million, EBITDA reached PLN 14.8 million, and net profit totaled PLN 4.3 million. A 2% year-on-year increase in export sales and the associated revenues helped offset the economic consequences of ongoing military conflicts and weakening demand in the domestic market.

The first half of 2026 was marked by an exceptionally challenging economic environment. Geopolitical tensions in the Middle East, including threats to the security of maritime transport through the Strait of Hormuz, contributed to increased uncertainty in commodity and fuel markets, thereby driving up operating costs for industrial companies. Under these conditions, Dr. Miele Cosmed Group maintained its stable market position, generating sales revenue of PLN 241.2 million, compared with PLN 249.1 million in the corresponding period of the previous year.

"The escalation of conflicts in the Middle East and the risks facing maritime transport in the Strait of Hormuz region have affected commodity and fuel prices, which in turn have increased operating costs for manufacturing companies. At the same time, consumers remained cautious in their purchasing decisions during the first half of the year. In such circumstances, the geographic diversification of sales and the consistent implementation of investments aimed at enhancing the efficiency and competitiveness of our production facilities become particularly important," commented Magdalena Miele, President of the Management Board of Dr. Miele Cosmed Group S.A.

Despite the unfavorable market environment, the Group continued to execute its strategic investment program. In the first half of 2026, capital expenditures exceeded PLN 14 million, while the value of property, plant and equipment increased to PLN 178.3 million. Investments were focused primarily on modernizing machinery, automating production processes, and implementing projects designed to improve operational efficiency.

The continued growth of international sales remains a key factor supporting the stability of the Group's operations. Revenue generated outside Poland amounted to PLN 151.2 million and accounted for 63% of total Group sales, compared with 61% a year earlier. The increasing contribution of foreign markets effectively mitigates the impact of the slowdown observed in the domestic market and confirms the effectiveness of the Group's diversification strategy.

"Our brands and collaborations with international business partners enable us to build solid foundations for future growth. The ongoing product portfolio renewal within the Sofin brand, one of the strongest contributors to our revenue stream, allows us to view sales prospects for the final months of the year with optimism," added Magdalena Miele.

Earlier from Dr. Miele Cosmed

All Dr. Miele Cosmed news releases